Non-Award
This course provides health professionals with a comprehensive understanding of treatment-resistant schizophrenia (TRS), including its epidemiology, assessment, and treatment. It offers practical tools and knowledge for immediate application in clinical practice.
Gain contemporary skills and knowledge.
Approximately 30% of people with schizophrenia have treatment-resistant schizophrenia (TRS), meaning they have not responded to at least two antipsychotic trials.
Research into TRS is ongoing, with developments in assessment and treatment helping to improve the functional outcomes and quality of life of individuals and their carers.
This self-guided online course brings together the latest research and developments in clinical practice to provide health professionals with a comprehensive understanding and up-to-date summary of the epidemiology, assessment and treatment of TRS. For those with an understanding of TRS, it provides a refresher in these key areas.
Developed by experts from the Department of Psychiatry, the course is equivalent to one hour of continuing professional development, subject to peer group approval.
Gain deeper knowledge of treatment-resistant schizophreniaAdvance your understanding of treatment-resistant schizophrenia by exploring its epidemiology. Use this knowledge to better understand the evaluation of TRS as well as medication and management.
Examine the role of clozapine in treatmentExplore the role of clozapine and monitoring requirements, as well as clozapine resistance and augmentation.
Gain practical tools to apply to your practiceFrom the evaluation of TRS through to medication and management, you'll gain practical knowledge and skills which you can apply immediately. Content also includes several practical tools, such as guidelines for assessment, which will be useful for your own practice.
Gain contemporary skills and knowledge.
Approximately 30% of people with schizophrenia have treatment-resistant schizophrenia (TRS), meaning they have not responded to at least two antipsychotic trials.
Research into TRS is ongoing, with developments in assessment and treatment helping to improve the functional outcomes and quality of life of individuals and their carers.
This self-guided online course brings together the latest research and developments in clinical practice to provide health professionals with a comprehensive understanding and up-to-date summary of the epidemiology, assessment and treatment of TRS. For those with an understanding of TRS, it provides a refresher in these key areas.
Developed by experts from the Department of Psychiatry, the course is equivalent to one hour of continuing professional development, subject to peer group approval.
Advance your understanding of treatment-resistant schizophrenia by exploring its epidemiology. Use this knowledge to better understand the evaluation of TRS as well as medication and management.
Explore the role of clozapine and monitoring requirements, as well as clozapine resistance and augmentation.
From the evaluation of TRS through to medication and management, you'll gain practical knowledge and skills which you can apply immediately. Content also includes several practical tools, such as guidelines for assessment, which will be useful for your own practice.
This course is designed for qualified psychiatrists and general practitioners working in mental health. Allied mental health professionals and psychologists working with people who have schizophrenia will also benefit from this course.
There are no eligibility requirements.
This course has been developed in close consultation with industry.
You will gain practical knowledge and skills in the evaluation of TRS through to medication and management, which you can apply to your practice immediately. This will allow you to provide higher quality patient care to those with this condition.
This module is equivalent to one hour of CPD, subject to peer group approval.
You will explore the key aspects of epidemiology, assessment and treatment of TSR through four topics:
Content also includes several practical tools, such as guidelines for assessment, which will be useful for your own practice.
This course has been developed and designed by Head of the Melbourne Medical School and professor of medicine, John Prins, and senior lecturer at the Department of Psychiatry, Mahesh Jayaram, in close consultation with industry.